Core Viewpoint - Zomedica Corp. has expanded its TRUFORMA diagnostic platform to include feline testing capabilities for its cobalamin and folate assay, marking a significant advancement in veterinary diagnostics [1] Group 1: Product Development - The TRUFORMA diagnostic platform now offers a multiplexed assay that combines cobalamin and folate testing, which was previously available only for canine patients [1] - This assay is the first of its kind to provide both cobalamin and folate testing in an in-clinic setting, enhancing the diagnostic capabilities for veterinarians [1] Group 2: Market Position - Zomedica is positioned as an innovative veterinary health company focused on point-of-care diagnostic and therapeutic device products for both equine and companion animals [1]

MARKHAM, ON / ACCESS Newswire / September 22, 2025 / iFabric Corp. ("iFabric" or the "Company") (TSX:IFA)(OTCQX:IFABF) today announced that its wholly owned subsidiary, Intelligent Fabric Technologies (North America) Inc. ("IFTNA"), has renewed its license agreement with TUMI, Inc. ("TUMI") to continue integrating IFTNA's PROTX2® antimicrobial solutions across select TUMI products. The renewal extends the relationship first announced on May 5, 2021, by a further period of five years. ...

Inverite Achieves Milestone SOC 2(R) Type II Audit Validation and Data Security ControlsSeptember 18, 2025 8:00 AM EDT | Source: Inverite Insights Inc.Vancouver, British Columbia--(Newsfile Corp. - September 18, 2025) - Inverite Insights Inc. (CSE: INVR) (OTC Pink: INVRD) (FSE: 2V0) ("Inverite") is a leading AI-driven software provider utilizing real-time financial data to empower businesses to transact more effectively with consumers, today announced it has successfully completed its SOC 2® T ...

Core Insights - Zomedica Corp. has strengthened its intellectual property portfolio with the issuance of four additional U.S. patents for its TRUVIEW and TRUFORMA diagnostic platforms [1] - The veterinary diagnostics market is currently valued between $8 billion and $11 billion and is projected to grow to $17 billion to $22 billion by 2030-2032, with a compound annual growth rate (CAGR) of 9-11% [1] Company Summary - Zomedica now holds a total of 228 patents and 153 trademarks, providing robust protection for its product platforms [1] - The company focuses on innovative point-of-care diagnostic and therapeutic device products for equine and companion animals [1]

Core Viewpoint - enVVeno Medical Corporation is seeking to appeal the not-approvable letter from the FDA regarding its VenoValve® device for treating severe deep chronic venous insufficiency [1] Group 1: Company Actions - The company plans to file a request for a supervisory appeal to challenge the FDA's decision received on August 19, 2025 [1] - The appeal will utilize the FDA's internal mechanisms to contest the review staff's decision, which may involve scientific controversies [1] Group 2: Product Information - The VenoValve® is a surgical replacement venous valve designed for the treatment of severe deep chronic venous insufficiency (CVI) [1]

Core Insights - Zomedica Corp. is showcasing its TRUVIEW digital cytology microscope in a webinar series aimed at innovation in veterinary care [1] - The TRUVIEW microscope enhances digital cytology and hematology practices by enabling rapid and high-quality image capture and interpretation [1] Company Overview - Zomedica is a veterinary health company focused on advanced diagnostic and therapeutic solutions for companion and equine animals [1] Industry Impact - The introduction of the TRUVIEW microscope represents a significant advancement in veterinary diagnostic technology, potentially improving the efficiency and accuracy of veterinary practices [1]

Core Insights - Horizon Kinetics Holding Corporation upgraded to OTCQX from OTCID™ Basic Market, enhancing its market visibility and trading status [1] Company Summary - Horizon Kinetics Holding Corporation is the holding company for Horizon Kinetics Asset Management LLC [1] - The company began trading on OTCQX under the symbol "HKHC" on September 5th, 2025 [1]

Company Overview - Burcon NutraScience Corporation is a global technology leader in plant-based protein innovation, focusing on high-performance plant-based proteins for the food and beverage industry [5] - The company has a strong patent portfolio covering novel proteins derived from various plant sources, including pea, canola, soy, hemp, and sunflower [5] Recent Developments - Burcon has successfully commenced commercial production of Puratein®C, a high-purity canola protein isolate with over 90% protein content, available for immediate delivery [1][3] - The production milestone is a significant step in Burcon's strategy to scale revenue and expand its portfolio of next-generation plant proteins [1][2] Product Details - Puratein C is extracted from non-GMO, North American-grown canola seeds and features a complete amino acid profile, including all nine essential amino acids [3] - The product has a Protein Digestibility-Corrected Amino Acid Score (PDCAAS) of 1, indicating its high nutritional value [3] - Puratein C is suitable for a wide range of applications, including dairy alternatives, ready-to-drink beverages, meat analogues, sauces, and baked goods [3] Market Opportunity - The global demand for high-quality, sustainable protein is accelerating, positioning Burcon's proprietary canola protein technology as a compelling solution [2] - The successful production of three proteins at commercial scale demonstrates Burcon's technology platform and execution capability, creating multiple new revenue streams [2]

Core Insights - The article emphasizes the importance of identifying investment opportunities where intrinsic value diverges from market price, particularly focusing on undervalued companies [1] - A specialized interest in Real Estate Investment Trusts (REITs) is highlighted, suggesting that the REIT sector offers significant potential for long-term growth [1] - The investment approach is grounded in fundamental analysis, prioritizing financial health, competitive positioning, and management quality [1] Group 1 - The author has a solid foundation in finance, developed through academic studies and hands-on research projects [1] - There is a strong emphasis on thorough research and analysis across various companies to uncover hidden investment gems [1] - The goal is to generate sustainable returns by adhering to a disciplined investment philosophy [1] Group 2 - The article indicates that the REIT sector presents abundant opportunities for investors due to its unique dynamics [1] - The focus on due diligence is crucial, as it involves evaluating key factors that influence a company's performance [1] - The author aims to identify undervalued REITs that are poised for substantial appreciation [1]

Group 1 - Ryder Systems' stock price has increased by over 20% since the initial coverage, outperforming the S&P 500, which returned less than 10% [1] - The analysis emphasizes a value investing approach, focusing on high-quality, mid and small-cap companies [1] - The author utilizes data analytics skills to identify promising investment opportunities from SEC filings and other data sources [1] Group 2 - The article does not contain any stock, option, or derivative positions related to the companies mentioned [2] - The opinions expressed in the article are solely those of the author and do not reflect the views of Seeking Alpha as a whole [3]